Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 952469, 6 pages
http://dx.doi.org/10.1155/2013/952469
Research Article

Depletion of Regulatory T Cells in a Mouse Experimental Glioma Model through Anti-CD25 Treatment Results in the Infiltration of Non-Immunosuppressive Myeloid Cells in the Brain

1Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences Kulak, E. Sabbelaan 53, 8500 Kortrijk, Belgium
2Department of Neurosciences, Laboratory of Experimental Neurosurgery and Neuroanatomy, KU Leuven, Herestraat 49, ON1, Box 811, 3000 Leuven, Belgium
3Laboratory of Pediatric Immunology, Department of Microbiology and Immunology, KU Leuven, Herestraat 49, ON1, Box 811, 3000 Leuven, Belgium
4Bioceros B.V., Alexander Numan Building 2nd floor, Yalelaan 46, 3584 CM Utrecht, The Netherlands

Received 1 February 2013; Revised 2 April 2013; Accepted 3 April 2013

Academic Editor: Mohamad Mohty

Copyright © 2013 Wim Maes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Zitvogel, A. Tesniere, and G. Kroemer, “Cancer despite immunosurveillance: immunoselection and immunosubversion,” Nature Reviews Immunology, vol. 6, no. 10, pp. 715–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Wainwright, I. V. Balyasnikova, A. L. Chang et al., “IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival,” Clinical Cancer Research, vol. 18, no. 22, pp. 6110–6121, 2012. View at Google Scholar
  3. L. Vandenberk and S. W. Van Gool, “Treg infiltration in glioma: a hurdle for antiglioma immunotherapy,” Journal of Immunotherapy, vol. 4, no. 7, pp. 675–678, 2012. View at Google Scholar
  4. C. A. Crane, B. J. Ahn, S. J. Han, and A. T. Parsa, “Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy,” Journal of Neuro-Oncology, vol. 14, no. 5, pp. 584–595, 2012. View at Google Scholar
  5. J. F. M. Jacobs, A. J. Idema, K. F. Bol et al., “Prognostic significance and mechanism of Treg infiltration in human brain tumors,” Journal of Neuroimmunology, vol. 225, no. 1-2, pp. 195–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Heimberger, M. Abou-Ghazal, C. Reina-Ortiz et al., “Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas,” Clinical Cancer Research, vol. 14, no. 16, pp. 5166–5172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. Curtin, M. Candolfi, T. M. Fakhouri et al., “Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials,” PLoS ONE, vol. 3, no. 4, Article ID e1983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Agarwalla, Z. Barnard, P. Fecci, G. Dranoff, and W. T. Curry Jr., “Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors,” Journal of Immunotherapy, vol. 35, no. 5, pp. 385–389, 2012. View at Google Scholar
  9. P. E. Fecci, H. Ochiai, D. A. Mitchell et al., “Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function,” Clinical Cancer Research, vol. 13, no. 7, pp. 2158–2167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Y. Kong, M. K. Abou-Ghazal, J. Wei et al., “A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells,” Clinical Cancer Research, vol. 14, no. 18, pp. 5759–5768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. C. Lutsiak, R. T. Semnani, R. De Pascalis, S. V. S. Kashmiri, J. Schlom, and H. Sabzevari, “Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide,” Blood, vol. 105, no. 7, pp. 2862–2868, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Maes, G. G. Rosas, B. Verbinnen et al., “DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma,” Neuro-Oncology, vol. 11, no. 5, pp. 529–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. O. M. Grauer, R. P. M. Sutmuller, W. Van Maren et al., “Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model,” International Journal of Cancer, vol. 122, no. 8, pp. 1794–1802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Maes, C. Deroose, V. Reumers et al., “In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma,” Journal of Neuro-Oncology, vol. 91, no. 2, pp. 127–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. E. L. Andaloussi, Y. U. Han, and M. S. Lesniak, “Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors,” Journal of Neurosurgery, vol. 105, no. 3, pp. 430–437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Wainwright, S. Sengupta, Y. Han, and M. S. Lesniak, “Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors,” Journal of Neuro-Oncology, vol. 13, no. 12, pp. 1308–1323, 2011. View at Google Scholar
  17. G. Kohanbash and H. Okada, “Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development,” Immunological Investigations, vol. 41, no. 6-7, pp. 658–679, 2012. View at Google Scholar
  18. D. Lindau, P. Gielen, M. Kroesen, P. Wessling, and G. J. Adema, “The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells,” The Journal of Immunology, vol. 138, no. 2, pp. 105–115, 2013. View at Google Scholar
  19. Y. Y. Setiady, J. A. Coccia, and P. U. Park, “In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes,” European Journal of Immunology, vol. 40, no. 3, pp. 780–786, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Sampson, R. J. Schmittling, G. E. Archer et al., “A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma,” PLoS One, vol. 7, no. 2, Article ID e31046, 2012. View at Publisher · View at Google Scholar